Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donata Santarsiero

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cells|March 11, 2023
The Complement System in Kidney TransplantationDonata Santarsiero, Sistiana Aiello
Kidney International Reports|April 13, 2026
Response to the Letter to the Editor Entitled "Defining "Dominance" in Atypical Hemolytic Uremic Syndrome: Distinguishing Amplification From Initiation"Sistiana Aiello, Donata Santarsiero, Sara Gastoldi, et al.
Kidney International Reports|January 22, 2026
Complement Alternative Pathway Dominance in Atypical Hemolytic Uremic Syndrome Revealed by Endothelial BioassaysDonata Santarsiero, Sara Gastoldi, Valeria Guaschino, et al.
Frontiers in Immunology|February 27, 2023
An <i>ex vivo</i> test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndromeSara Gastoldi, Sistiana Aiello, Miriam Galbusera, et al.
Kidney International Reports|November 13, 2024
Exuberant Endothelial C5b-9 Formation in Recurrent and <i>De Novo</i> Posttransplant Thrombotic MicroangiopathySistiana Aiello, Sara Gastoldi, Elena Bresin, et al.
Blood Advances|December 1, 2021
C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19Sistiana Aiello, Sara Gastoldi, Miriam Galbusera, et al.
Frontiers in Immunology|July 7, 2025
C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patientsValeria Guaschino, Donata Santarsiero, Sara Gastoldi, et al.
Frontiers in Immunology|March 30, 2026
Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosisDonata Santarsiero, Miriam Galbusera, Sara Gastoldi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cells|March 11, 2023
The Complement System in Kidney TransplantationDonata Santarsiero, Sistiana Aiello
Kidney International Reports|April 13, 2026
Response to the Letter to the Editor Entitled "Defining "Dominance" in Atypical Hemolytic Uremic Syndrome: Distinguishing Amplification From Initiation"Sistiana Aiello, Donata Santarsiero, Sara Gastoldi, et al.
Kidney International Reports|January 22, 2026
Complement Alternative Pathway Dominance in Atypical Hemolytic Uremic Syndrome Revealed by Endothelial BioassaysDonata Santarsiero, Sara Gastoldi, Valeria Guaschino, et al.
Frontiers in Immunology|February 27, 2023
An <i>ex vivo</i> test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndromeSara Gastoldi, Sistiana Aiello, Miriam Galbusera, et al.
Kidney International Reports|November 13, 2024
Exuberant Endothelial C5b-9 Formation in Recurrent and <i>De Novo</i> Posttransplant Thrombotic MicroangiopathySistiana Aiello, Sara Gastoldi, Elena Bresin, et al.
Blood Advances|December 1, 2021
C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19Sistiana Aiello, Sara Gastoldi, Miriam Galbusera, et al.
Frontiers in Immunology|July 7, 2025
C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patientsValeria Guaschino, Donata Santarsiero, Sara Gastoldi, et al.
Frontiers in Immunology|March 30, 2026
Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosisDonata Santarsiero, Miriam Galbusera, Sara Gastoldi, et al.
Pageof 1